A single oral administration of MM120 (lysergide d-tartrate), an investigational lysergic acid diethylamide (LSD)–based medicine being developed by Mind Medicine Inc (MindMed), provided rapid and durable […]

High olive oil consumption is associated with a significant decreased risk for dementia-related mortality, regardless of overall diet quality, a new study suggested. Data from a […]

A novel training program that uses theater and improv can help empower Asian American, Native Hawaiian, and Pacific Islander (AANHPI) medical students faced with racial bias […]

About 85% of patients with opioid use disorder (OUD) are described in clinical notes as being abusers, addicts, junkies, or with other stigmatizing terms, preliminary results […]

Attention-deficit/hyperactivity disorder (ADHD) in adults is independently associated with an increased risk for dementia with Lewy bodies (DLB), dementia, and nonamnestic mild cognitive impairment (naMCI), results […]

Serious mental illness (SMI), including bipolar disorder or schizophrenia spectrum disorders, is associated with a twofold increased risk for comorbid physical illness, results of a new […]

The US Drug Enforcement Agency (DEA) is moving forward with plans to move marijuana from a Schedule I to a Schedule III controlled substance under the […]

Noninvasive transcranial alternating current stimulation (tACS) may lead to rapid improvement in major depressive disorder (MDD), results of a randomized, sham-controlled trial suggested. However, independent experts […]